SINSINPAS LIDOCAINE PAIN RELIEVING

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
SINSINPAS LIDOCAINE PAIN RELIEVING
Generic name
LIDOCAINE
Manufacturer
Sinsin Pharmaceutical Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
82c0a036-8750-5b3d-e053-2a91aa0a1815
SPL ID
40969e2f-7ecb-0030-e063-6294a90aa30a
Version
28
Effective date
2025-10-07
Source export date
2026-09-28
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:29:25
Harmonized routes table
Harmonized routes
CUTANEOUS, TOPICAL, TRANSDERMAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use more than 1 patch at a time on broken, irritated, or swollen skin on puncture wounds for more than one week without consulting a doctor When using this product use only as directed. Read and follow all direction and warning on this label Avoid contact with the eyes or mucous membranes Do not apply to broken, damaged, or irritated skin Do not bandage tightly or apply local heat (such as heating pads) to the area of use Rare cases of serious burns have been reported with products of this type Do not use with other topical analgesics Keep children and pets away from used or disposed patch. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this product.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.